Tuesday, August 04, 2020 4:28:36 PM
Brilacidin for ABSSSI is ph3 ready. Ph2 was dosed via IV in hundreds of patients.
Brilacidin for OM is ph3 ready. Ph2 was dosed via swish and spit.
Brilacidin for UP ph 2 POC trial was dosed with water enema. Results good enough that Alfasigma licensed Brilacidin for UP dosing with foam, enema, or gel.
Brilacidin for UC ph 1 was dosed with Oralogic tablet.
*****
http://www.ipharminc.com/press-release/2020/5/26/innovation-pharmaceuticals-receives-data-from-public-health-research-institute-showing-brilacidin-inhibits-sars-cov-2-covid-19-in-a-human-cell-line
Quote:
· Brilacidin showed a dose-dependent inhibitory response in a human kidney cell line expressing hACE2
· Data supports Brilacidin’s potential to prevent SARS-CoV-2 binding to the hACE2 receptor, the method by which the novel coronavirus gains entry in human cells
*****
https://www.globenewswire.com/news-release/2020/06/11/2046799/0/en/Innovation-Pharmaceuticals-Collaborating-with-Regional-Biocontainment-Lab-on-Grant-Application-to-Research-Brilacidin-as-a-Pan-Coronavirus-Therapeutic.html
Quote:
a clinical stage biopharmaceutical company, announces today the Company and researchers at a U.S. Regional Biocontainment Laboratory (RBL) are collaborating on a federal grant application to be submitted this week.
This is likely to have been submitted on Friday the 12th and, that is the date I’ll be using for my purposes.
Quote:
The proposed research aims to evaluate Brilacidin as a potential pan-coronavirus therapeutic, for treating SARS-CoV-2, SARS-CoV-1 and MERS-CoV, including extending the current in vitro testing of Brilacidin to in vivo testing.
The question remains as to whether or not this grant is approved. This will be helped by the fact testing is being conducted by US RBL's and not internal company testing. Imagine the benefit if Brilacidin shows to be active in other virus's. Especially, the common cold.
Probability is finally on our side as shareholders due to the seriousness and intensity of the global concern surrounding covid. The science is also with us.
In vitro results have been very good in human lung and kidney cells. The safety has been proven in 3 FDA studies with about 500 patients. Immunomodulation will likely reduce pulmonary and inflammatory complications. The virucidal MOA results in faster viral clearance. And, the broad spectrumm antibiotic will likely reduce high rate of secondary infection. It's the only treatment with 3 MOA which should reduce drug resistance. The good pharmockinetics with long half life will increase antiviral effect and reduce may reduce frequency of dosing.
And, I don’t believe Leo would make false covid claims with the SEC watching this arena closely.
SEC Charges Companies and CEO for Misleading COVID-19 Claims
https://www.sec.gov/news/press-release/2020-111
Message in reply to:
Can’t believe you’re still in this. My God what a long ride. Been riding it out with ATNM longer than this so I know how it feels. Saw your post about ECOR the other day, I’ve been in that since .80.
Good luck, it only takes 1 bio to be life changing. Mine was AUPH. Lots of swings and misses along the way. Disagree with you on this one and on Leo but you never know.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM